Common aspirin may hold key to preventing Women's cancer
NCT ID NCT07281547
Summary
This study is testing whether low-dose aspirin can reduce inflammation and prevent endometrial (uterine) cancer in postmenopausal women who have certain tissue changes. Researchers will enroll 25 women who are already scheduled for a biopsy and randomly assign them to take aspirin or not. The main goal is to see if aspirin lowers specific inflammation markers in the uterine tissue that are linked to cancer development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
Contact Phone: •••-•••-••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.